IUPAC/Chemical Name
(E)-hex-3-ene-3,4-diylbis(4,1-phenylene) bis(bis(2-chloroethyl)carbamate)
InChi Key
BOIZOYRDXIYMCY-OCEACIFDSA-N
InChi Code
1S/C28H34Cl4N2O4/c1-3-25(21-5-9-23(10-6-21)37-27(35)33(17-13-29)18-14-30)26(4-2)22-7-11-24(12-8-22)38-28(36)34(19-15-31)20-16-32/h5-12H,3-4,13-20H2,1-2H3/b26-25+
SMILES Code
CC\C(=C(\CC)C1=CC=C(OC(=O)N(CCCl)CCCl)C=C1)C2=CC=C(OC(=O)N(CCCl)CCCl)C=C2
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
604.39
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Zimel H, Dimitriu L, Mîndroiu T, Mateescu GH, Gălăţeanu I, Marinescu M, Arsene J. Scanning of the prostate with Stilbostat-131I. Endocrinologie. 1977 Apr-Jun;15(2):127-31. PMID: 559345.
2: Görlich M, Heise E. Contribution to the mechanism of Stilbostat action. Neoplasma. 1976;23(4):363-9. PMID: 1004653.
3: Zimel H, Bocancea D. Treatment of prostatic carcinoma with Stilbostat. Neoplasma. 1974;21(1):101-8. PMID: 4596007.
4: Zimel A, Taşcă C, Ghinea E, Stefäneanu L. Influence of the "Corynebacterium parvum" vaccine and stilbostat on intratesticular development of Walker 256 carcinosarcoma in hyper- or hypothyroidized Wistar rats. Endocrinologie. 1981 Apr-Jun;19(2):105-10. PMID: 7256164.
5: Zimel H, Broder D, Zimel A. Efectele terapeutice ale preparatului "stilbostat" în cancerul mamar în stadii avansate după menopauză [Therapeutic effects of the preparation "Stilbostat" in advanced stages of breast cancer after the menopause]. Stud Cercet Endocrinol. 1973;24(3):211-9. Romanian. PMID: 4703920.
6: Zimel H, Zimel A, Petrescu R, Ghinea E, Tasca C. Influence of stress and of endocrine imbalance on the experimental metastasis. Neoplasma. 1977;24:151-9. PMID: 865645.
7: Zimel H, Mogos I, Maltezeanu G. Estimation of StilbostatR treatment efficiency in breast cancer by thermography. Neoplasma. 1977;24(5):553-7. PMID: 927612.